» CRYOcheck™ Chromogenic Factor VIII

HEMOSTASIS COAGULATION ROUTINE FACTOR ASSAYS CHROMOGENIC ASSAYS FACTOR VIII

CRYOcheck™ Chromogenic Factor VIII

Colorimetric assay

CRYOcheck™ Chromogenic Factor VIII is a chromogenic assay used for the colorimetric quantitative determination of Factor VIII activity in citrated human plasma.

Access publications on the manufacturer's website

Reference	CCCF08
Presentation	Kit
Number of assays	4 x 20
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Number of assays	Quote	Product sheet
CCCF08	Kit	4 x 20

Price list, safety data sheets and notices are accessible to our registered customers.

Factor VIII is a glycoprotein mainly synthesized by the liver. It circulates in the plasma as bound to vWF which protects it from rapid proteolytic degradation.
It is activated by FXa or thrombin in FVIIIa which will complex with FIXa in the presence of phospholipids to activate FX in FXa.
A patient who is deficient in FVIII has hemophilia A.

CRYOcheck™Chromogenic Factor VIII is used to identify FVIII deficiency and helps in the management of hemophilia A in people 2 years of age and older.

- Linearity: 0-200%
- Detection limit: 0.5% (activity%)
- Accuracy <4%
- 24 hours stability of reagents on analyzers
- Reagents refreezable 30 days at -70 ° C

- 4 vials of reagent 1 (bovine FX + fibrin inhibitor) (1.25 mL)
- 4 vials of reagent 2 (human FIIa, human FIXa, Ca ++ , phospholipids) (1.25 mL)
- 4 vials of reagent 3 (FXa substrate + thrombin inhibitor) (1.25 mL)
- 4 vials of Tris-BSA Dilution Buffer (7 mL)

CRYOcheck™ Abnormal 1 Reference Control
CRYOcheck™ Abnormal 2 Reference Control
CRYOcheck™ Normal Reference Plasma
CRYOcheck™ Reference Control Normal

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE FACTOR ASSAYS CHROMOGENIC ASSAYS FACTOR VIII